MENU
VYNE
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
VYNE Therapeutics (VYNE) Ownership - Who owns VYNE Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
685 Route 202/206 North
Phone
+1 800 775-7936
Employees
10
Web
https://www.vynetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.73M
P/E Ratio
1.09
Total Cash
78.1M
Projected Growth
N/A
Total Debt
145K
Revenue
486K
Risk (Beta)
2.51
Dividend Yield
N/A
Total Cash/Share
5.30
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
VYNE
Capitalization
27.7M
P/E Ratio
1.09
Risk (Beta)
2.51
Dividend Yield
N/A
Total Cash
78.1M
Total Cash/Share
5.30
Total Debt
145K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
486K
ROE
N/A
Book Value
74.9M
P/B Ratio
0.37
Cash Flow
N/A
Earnings
1.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
7.13
Current Revenue Per Employee
19800.00
Dividends Per Share - Security
N/A
EBITDA
-30.84M
Float
N/A
Float - Current
N/A
Gross Income Margin
60.60
Revenue To Assets
-50.94
Shares Held By Institutions
16.7M
Shares Outstanding - Current
14.7M
Total Liabilities
11.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-6.867
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in development and commercialization of serlopitant products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
685 Route 202/206 North
Phone
+1 800 775-7936
Employees
10
Web
https://www.vynetherapeutics.com